spartalizumab,capmatinib
novartis
['nsclc', 'capmatinib', 'sclc', 'spartalizumab']
#esmo22 | poster session 14 | saturday
efficacy and safety of capmatinib plus spartalizumab in treatment-na ve patients with advanced nsclc harboring met exon 14 skipping mutation
co-author: rebecca heist, md, mph 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.